As the European Falsified Medicines Directive (EU FMD) compliance deadline gets closer, companies who have not yet prepared for serialization will have no choice but to outsource to meet the requirements in time. Tackling serialization independently is simply not an option at this stage, as time is too tight. Engaging with expert contractors, such as a contract packaging organisation (CPO), can make the process more straightforward.
In this article with European Pharmaceutical Manufacturer, Dexter Tjoa, Director Corporate Strategy, explains why outsourcing is quickly becoming a necessary decision for companies who have not yet begun preparations for the upcoming EU FMD deadline in February 2019. He also discusses the benefits of involving an experienced CPO to meet compliance in time.
You can read the article in full here.
Ready to shape the future of your pharmaceutical supply chain?